BDBM593213 N-((1R,4R)-4-(((5-fluoro-2-((1-(2- methoxyethyl)-1H-pyrazol-4- yl)amino)pyrimidin-4- yl)oxy)methyl)cyclohexyl) acetamide::US11578061, Example 191
SMILES COCCn1cc(Nc2ncc(F)c(OC[C@H]3CC[C@@H](CC3)NC(C)=O)n2)cn1
InChI Key InChIKey=SJDBWLAGXARLMW-UHFFFAOYSA-N
Data 1 IC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 1 hit for monomerid = 593213
TargetLeucine-rich repeat serine/threonine-protein kinase 2 [970-2527](Human)
Halia Therapeutics
US Patent
Halia Therapeutics
US Patent
Affinity DataIC50: 50nMAssay Description:LRRKtide substrate (peptide sequence RLGRDKYKTLRQIRQ, derived from human ezrin [amino acids 561-573], moesin [amino acids 539-553] and radixin [amino...More data for this Ligand-Target Pair
